Patents by Inventor Nadja Herbach

Nadja Herbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7919673
    Abstract: The present invention relates to transgenic pigs containing a dominant-negative incretin hormone receptor, namely the dominant-negative human glucose-dependent insulinotropic polypeptide receptor. The present invention furthermore relates to uses of these transgenic pigs as clinically relevant animal model systems for studying the pathogenesis and novel therapies for diabetes mellitus type 2, particularly for the maintenance and expansion of pancreatic ?-cell mass.
    Type: Grant
    Filed: January 4, 2009
    Date of Patent: April 5, 2011
    Assignees: Ludwig-Maximilians-Universitat, MWM Biomodels GmbH
    Inventors: Eckhard Wolf, Simone Renner, Barbara Kessler, RĂ¼diger Wanke, Nadja Herbach, Alexander Pfeifer, Andreas Hofmann
  • Publication number: 20090228993
    Abstract: The present invention relates to transgenic pigs containing a dominant-negative incretin hormone receptor, namely the dominant-negative human glucose-dependent insulinotropic polypeptide receptor. The present invention furthermore relates to uses of these transgenic pigs as clinically relevant animal model systems for studying the pathogenesis and novel therapies for diabetes mellitus type 2, particularly for the maintenance and expansion of pancreatic ?-cell mass.
    Type: Application
    Filed: January 4, 2009
    Publication date: September 10, 2009
    Inventors: Eckhard Wolf, Simone Renner, Barbara Kessler, Rudiger Wanke, Nadja Herbach, Alexander Pfeifer, Andreas Hofmann